Dysplasia and tumor discrimination in brain tissues by combined fluorescence, Raman, and diffuse reflectance spectroscopies
Year: 2023
Authors: Baria E., Giordano F., Guerrini R., Caporalini C., Buccoliero A.M., Cicchi R., Pavone F.S.
Autors Affiliation: CNR, Natl Inst Opt, Via Nello Carrara 1, I-50019 Sesto Fiorentino, Italy; Univ Florence, European Lab Nonlinear Spect, Via Nello Carrara 1, I-50019 Sesto Fiorentino, Italy; A Meyer Childrens Hosp, Dept Neurosci 1, Div Neurosurg, Viale Gaetano Pieraccini 24, I-50141 Florence, Italy; Univ Florence, Dept Crit Care Med & Surg, Div Pathol, Viale Giovanni Battista Morgagni 85, I-50134 Florence, Italy; Univ Florence, Dept Phys & Astrophys, Via Sansone 1, I-50019 Sesto Fiorentino, Italy.
Abstract: Identification of neoplastic and dysplastic brain tissues is of paramount importance for improving the outcomes of neurosurgical procedures. This study explores the combined application of fluorescence, Raman and diffuse reflectance spectroscopies for the detection and classification of brain tumor and cortical dysplasia with a label-free modality. Multivariate analysis was performed to evaluate classification accuracies of these techniques–employed both in individual and multimodal configuration–obtaining high sensitivity and specificity. In particular, the proposed multimodal approach allowed discriminating tumor/dysplastic tissues against control tissue with 91%/86% sensitivity and 100%/100% specificity, respectively, whereas tumor from dysplastic tissues were discriminated with 89% sensitivity and 86% specificity. Hence, multimodal optical spectroscopy allows reliably differentiating these pathologies using a non-invasive, label-free approach that is faster than the gold standard technique and does not require any tissue processing, offering the potential for the clinical translation of the technology.
Journal/Review: BIOMEDICAL OPTICS EXPRESS
Volume: 14 (3) Pages from: 1256 to: 1275
More Information: Funding. Fondazione Cassa di Risparmio di Firenze (banking foundation; Human Brain Optical Mapping) ; Tuscany Region (projects DECODEE, GLIOMICS, research program PAR FAS 2007-2013) ; EU Horizon 2020 Res earch and Innovation Programme (grant 654148 Laserlab-Europe, grant 871277 AMPLITUDE) ; Italian Ministry for Education, University and Research (Flagship Project NANOMAX) .KeyWords: Focal Cortical Dysplasia; Optical-properties; Label-free; Autofluorescence; Vivo; Neuroblastoma; GuidanceDOI: 10.1364/BOE.477035ImpactFactor: 2.900Citations: 4data from “WEB OF SCIENCE” (of Thomson Reuters) are update at: 2024-11-10References taken from IsiWeb of Knowledge: (subscribers only)Connecting to view paper tab on IsiWeb: Click hereConnecting to view citations from IsiWeb: Click here